Ciphergen Reports Rise in Revenues, Smaller Loss for Q1

May 07, 2004

NEW YORK, May 7 (GenomeWeb News) - Ciphergen Biosystems yesterday reported increased revenues and narrowed losses for the first quarter of the year.

The company's revenues totaled $15.5 million, up from $12.8 million in the first quarter of 2003.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.